Revolution Medicines, Inc. ( RVMD )  shares are trading higher Wednesday. The company announced the publication of several peer-reviewed research papers earlier in the week. 

The Details:

Revolution Medicines ( RVMD ) announced the publication of a peer-reviewed research paper in "Cancer Discovery" detailing the discovery and preclinical to clinical translation for RMC-6236 on Monday. 

The company also announced the publication of two peer-reviewed research papers in "Nature" Tuesday. The first paper highlights the discovery and preclinical characterization of RMC-7977, and the second paper highlights the systematic evaluation of RMC-7977 in a wide range of preclinical models of PDAC. 

“The research summarized in our Cancer Discovery paper, combined with the preliminary RMC-6236 clinical data presented in late 2023, provide us and our investigators with the confidence to advance and expand our RMC-6236 clinical development program,” said Steve Kelsey, M.D., president, research and development of Revolution Medicines ( RVMD ).

According to data from Benzinga Pro, Revolution Medicines ( RVMD ) shares are trading above the stock’s 50-day moving average of $30.53 and set a new intraday 52-week high of $37.50 Wednesday. 

Related News: What’s Going On With Chinese EV Stocks Nio And XPeng?

Is RVMD A Good Stock To Buy?

An investor can make a few decisions when deciding whether a stock is a good buy. In addition to valuation metrics and price action which you can find on Benzinga's quote pages – like Revolution Medicines ( RVMD )‘ page for example – there are factors like whether or not a company pays a dividend or buys a large portion of its stock each quarter.

These are known as capital allocation programs. Revolution Medicines ( RVMD ) does not pay a dividend, but obviously has a few ways it can return value to shareholders. Feel free to search Benzinga's dividend calendar for the next company that is due to pay a dividend and determine what kind of yield you can earn for holding a share of the company.

For example, if you're looking to earn an annualized return of 110.75%, you'll need to buy a share of Lufax Holding by June 4. Once done, you can expect to receive a nominal payout of $2.37 on June 8.

Buyback programs are obviously different and highly variable. A company can approve a buyback program and purchase shares as it sees fit over the course of time in which the buyback was authorized. Looking through the latest news on Revolution Medicines ( RVMD ) will often yield whether or not the company has approved a buyback program recently. Buyback programs usually serve as a support for share prices, serving as a backstop for demand.

RVMD Price Action: According to Benzinga Pro, Revolution Medicines ( RVMD ) shares are up 9.78% at $36.22 at the time of publication Wednesday.

Image: Studio Iris from Pixabay